Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

24 Dec 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives approvals from the USFDA for Doxycycline Hyclate Delayed-Release Tablets and Febuxostat Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..